AUGUST 2024: GRANT FROM MJFF FOR SUBCONTRACT WITH INFLAMMANOVA RX – The Cowell Lab was awarded a subcontract as part of a larger award to InflammaNova RX from the Michael J. Fox Foundation entitled “Therapeutic Development of Novel STING Inhibitors to Treat Parkinson’s Disease Neuroinflammation.” This study will use a variety of methods to determine whether novel inhibitors of STING show evidence for target engagement in rodent models of inflammation and Parkinson’s Disease.
- Login
- |
- Privacy
- |
- Terms of Use
- |
- © 2025 The University of Alabama at Birmingham
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.